Valdoxan®/Thymanax® (agomelatine) is more efficacious than both conventional selective serotonin reuptake inhibitor (SSRI) and serotonin noradrenaline reuptake inhibitor (SNRI) antidepressants, according to new data presented today at the 23rd European College of Neuropsychopharmacology (ECNP) Congress.
To view Multimedia News Release, go to http://maultivu.prnewswire.com/mnr/prne/valdoxan/44196/
Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world’s largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child’s own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57707-cord-blood-registry-stem-cell-trials-child-autism
PTSD treatment 1 week on former Birmingham soldier Craig Burgess talks about the changes in his PTSD post traumatic stress disorder and how all the nightmares and flashbacks have stopped after just one session with Birmingham NLP hypnotherapist Debbie Williams. Get a free hypnosis recording Stop worrying and create a wonderful life form here http://www.debbiewilliamsassociates.co.uk/home.htm
The American Pain Foundation (APF) announced today the launch of new information and resources on pain medication safety for acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) as a part of its PainSAFE™ educational initiative. The new information will be launched with a national public service announcement (PSA) emphasizing the safe use of pain treatment options, particularly medications containing NSAIDs (aspirin, ibuprofen, naproxen) and acetaminophen (Tylenol, APAP). APF is the nation’s largest consumer advocacy organization dedicated to people with pain.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/painfoundation/49865/
Two beautiful baby girls had their public debut today at The Children’s Hospital of Philadelphia: Allison June and Amelia Lee Tucker, formerly conjoined twins, separated at the Hospital on Nov. 7. The Hospital held a press conference this morning to highlight this new phase in the lives of both infants.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59552-children-s-hospital-of-philadelphia-tucker-conjoined-twins-separated
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
http://adultadhdtreatmentblog.com/adult-adhd-treatment/
Grownup ADHD treatment is highlighted via this write-up. Even although ADHD - attention deficit/hyperactivity problem - is usually associated with small children, it also affects adults and troubles them during their whole lifetime. According to various studies there are substantial percentages of adults struggling with ADHD. Out of the population of ten million nearly the low of 1 percent to high of six % suffers from ADHD.
The problems of Grownups suffering from ADHD are different from the children. Adults don
ORBIS is excited to announce the return of its Flying Eye Hospital (FEH) to EAA AirVenture at Wittman Regional Airport in Oshkosh, Wisconsin. This is the first time since 2003 that the aircraft has been featured at the airshow – the largest gathering of aviation enthusiasts in the United States. ORBIS will be opening the aircraft’s doors at this year’s airshow, giving visitors the opportunity to tour the world’s only airborne ophthalmic training facility in the world. Today, ORBIS will announce details of its new FEH – a MD-10 aircraft that is currently undergoing transformation from a cargo plane into the next generation Flying Eye Hospital.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51620-orbis-flying-eye-hospital-airventure-oshkosh-airshow
Go
to http://www.youtube.com/watch?v=iEaPlJkCUfA Aurawave Pain Reliever As
Seen On TV treatment for your back pain. If you are sick and tired with
your body aches and pains. If you think the only solution for pain
reliever is to take over-the-counter pain relievers. Well, think again
with Aurawave Pain Reliever As Seen On TV, pain is gone.
Under the leadership of the National Organization for Rare Disorders (NORD), the primary organization in the U.S. representing people with rare diseases, millions of Americans will gather tomorrow to observe the 5th annual Rare Disease Day. This international observance unites people around the globe to focus attention on the estimated 300 to 350 million patients worldwide afflicted with rare diseases and to recognize that their needs are a global public health concern. In the U.S., a rare disease is one that affects fewer than 200,000 Americans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60507-nord-rare-disease-day
The Sanford Guide, recognized as the essential reference for infectious disease treatment, announced the release of its first mobile app for the iPhone, iPod touch and iPad. The Sanford Guide App, available on Apple’s App Store for $29.99, contains the comprehensive guidelines and recommendations featured in the well-known pocket-size guides used by health care professionals in treatment decision making for over 40 years.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/sanfordguide/50808/
At its annual meeting of more than 10,000 financial representatives and staff members today, Northwestern Mutual announced its new multi-year philanthropic program to fight childhood cancer. The effort, through the Northwestern Mutual Foundation, builds upon the company’s legacy of helping children and families. It leverages Northwestern Mutual’s field force throughout the country to implement a range of community events and programs to raise awareness and money for pediatric cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53645-northwestern-mutual-philanthropic-campaign-pediatric-cancer-research
